of their son. we re going to talk to evan gershkovich s freshman year college roommate in just a few minutes. we ll talk about the person he calls a, quote, exceptional friend and journalist. plus, we have breaking news to share. the man accused of shooting and killing 23 people at an el paso, texas, walmart in 2019 has just been sentenced to 90 consecutive life sentences on federal charges and that is just his first round of sentencing. we re going to have the very latest for you any moment when we get our nbc news reporter who s there on site for us. we begin this hour at the site where republican primary race begins, that being iowa. right now former president donald trump is hitting the campaign trail in council bluffs as he continues to campaign and fund-raise. the republican leader writing in a lengthy statement last night that the doj is going after him and claiming that special counsel jack smith, quote, purposefully omitted the presidential records act. are quote,
monoclonal antibodies during covid, they get rid of blacks, which are the buildup inside the brain which are partially responsible for alzheimer s. other drugs have gotten rid of those plaques. this is the first drug to actually show a slow in the decline of the cognition. in other words, it s not stopping it. it s not reversing it. it s just slowing that decline, 27% over 18 months, which is essentially the equivalent of giving them five months more of having that memory. okay. that s very important but you heard me mention the cost. enormous before insurance could come in and help pick up some of it. but it has to make you wonder about accessibility. do you have concerns about that. one is the cost and how it s administered. it s an iv infusion every two or three weeks. you have to get to the clinic, you have to get back home. some of this age group don t drive, they re going to have to rely on somebody to take them. the cost, cms who runs medicare came out with a statement sayin
reports in the coming months, alex. appreciate you, brian cheung, for that. and as we see another positive jobs report, is the pandemic s great resignation finally coming to an end? new york times economics writer ben castleman will join me on the current pace of job switching and what that means for wage growth. up next, a look inside the former military base in belarus that y yevgeny prigozhin was gog to make his new home. and a breakthrough alzheimer s treatment, what this could mean for the millions suffering from the disease and how much it s going to cost. easd how much it s going to cost. so you only pay for what you need. you could save $700 dollars just by switching. ooooh, let me put a reminder on my phone. on the top of the pile! oh. only pay for what you need. liberty. liberty. liberty. liberty. feeling. ughh .from a backed up gut? miralax works naturally with the water in your body to help you go.
are starting to worry, even republicans who don t want donald trump to carry the banner for the party next year, that even if desantis gets past donald trump, can he win a general election? yeah, okay, carlos curbelo, always good to talk with you, thank you so much. up next, fda approval for a breakthrough alzheimer s drug, the impact, the risks and the cost. and in our next hour, the house oversight committee s demands over cocaine found in the white house. the committee s chair calling it a shameful moment in the building s history. ent in the building s history depression ss were in my way. i needed more from my antidepressant. vraylar helped give it a lift. adding vraylar to an antidepressant. .is clinically proven to help relieve overall depression symptoms. .better than an antidepressant alone. and in vraylar clinical studies, most saw no substantial impact on weight. elderly dementia patients have increased risk of death or stroke. report unusual changes in behavior or suici
try new mirafiber gummies. well, the fda just approved the first drug to slow the progression of alzheimer s in what could be a major breakthrough for the nearly 7 million adults suffering from the degenerative disease here in the u.s., but the listed price tag, it is a hefty you ready for it? $26,000 before insurance, and some experts have concerns about side effects as well. so here to discuss all this with us is nbc news senior medical correspondent, dr. john torres. a lot of people are going to say this is great news. first of all, tell me how this works and how you think it will impact the slowing of alzheimer s? so the drug is called leqembi, lecanemab is the generic name. that mab is monoclonal antibodies. it essentially is using your immune system, think about the